MedPath

The Feasibility of Male Involvement in the Prevention of Mother to Child Transmission of HIV Services in Blantyre, Malawi

Not Applicable
Recruiting
Conditions
HIV/AIDS
Pregnancy and Childbirth
Registration Number
PACTR201311000675100
Lead Sponsor
ational Commission for Science and Terchnology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
462
Inclusion Criteria

Pregnant women, until 30 weeks gestation. Gestation period is limited to 30 weeks to allow room for adequate evaluation of the strategy as they report for antenatal care. Ascertainment of gestational age will be through fundal height assessments and or calculating from the Last Normal Menstrual Period date.
Pregnant women aged 16 years or older (and married) will be eligible because according to Malawian law, they are considered emancipated and are able to sign the consent form for themselves without parental consent.
If unmarried then they have to be 18 years of age and above in order to be enrolled because 18 is the legal age in Malawi for informed consent
Pregnant women must be attending antenatal care without a spouse.
Planning to attend antenatal Care at the study clinic.
Ability and willingness to provide informed consent before study participation
Pregnant women with a male partner responsible for the current pregnancy
Women should be willing to pass on the ¿invitation card¿ to the partner.

Exclusion Criteria

Postpartum women- Postpartum women will be excluded to avoid running the study for a long duration and also because there are only a few postpartum visits that postnatal women attend which may create a potential for loss to follow up in postpartum care.
Pregnant women with gestation over 30 weeks. Gestation above 30 weeks will not offer adequate time for follow up to assess uptake of the intervention.
Unwillingness to join the study.
Unwillingness to comply with study visits.
Women without a male partner.
Women who attend antenatal care with their spouse.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
proportion of pregnant women that are accompanied by their partners at week 2 and week 6 of the study after receipt of an Invitation card from the Health Centre and the non-intervention study arm.
Secondary Outcome Measures
NameTimeMethod
proportion of male partners taking up HIV testing in both study arms at study week 2 and 6.;proportion of women taking up PMTCT services such as HIV testing, Antiretrovirals (ARVs) for PMTCT, Infant feeding Options in both arms at study week 2 and 6.
© Copyright 2025. All Rights Reserved by MedPath